138 related articles for article (PubMed ID: 30990115)
1. L-Asparaginase from
Effer B; Lima GM; Cabarca S; Pessoa A; Farías JG; Monteiro G
Prep Biochem Biotechnol; 2019; 49(7):679-685. PubMed ID: 30990115
[TBL] [Abstract][Full Text] [Related]
2. Development of asparaginase Erwinia chrysanthemi for the treatment of acute lymphoblastic leukemia.
Salzer WL; Asselin BL; Plourde PV; Corn T; Hunger SP
Ann N Y Acad Sci; 2014 Nov; 1329():81-92. PubMed ID: 25098829
[TBL] [Abstract][Full Text] [Related]
3. L-Asparaginase from Erwinia Chrysanthemi 3937: cloning, expression and characterization.
Kotzia GA; Labrou NE
J Biotechnol; 2007 Jan; 127(4):657-69. PubMed ID: 16984804
[TBL] [Abstract][Full Text] [Related]
4. Extracellular expression of
Biasoto HP; Hebeda CB; Farsky SHP; Pessoa A; Costa-Silva TA; Monteiro G
Prep Biochem Biotechnol; 2023; 53(5):511-522. PubMed ID: 35981094
[TBL] [Abstract][Full Text] [Related]
5. Structural Insight into Substrate Selectivity of Erwinia chrysanthemi L-asparaginase.
Nguyen HA; Su Y; Lavie A
Biochemistry; 2016 Mar; 55(8):1246-53. PubMed ID: 26855287
[TBL] [Abstract][Full Text] [Related]
6. Safety profile of asparaginase Erwinia chrysanthemi in a large compassionate-use trial.
Plourde PV; Jeha S; Hijiya N; Keller FG; Silverman LB; Rheingold SR; Dreyer ZE; Dahl GV; Mercedes T; Lai C; Corn T
Pediatr Blood Cancer; 2014 Jul; 61(7):1232-8. PubMed ID: 24436152
[TBL] [Abstract][Full Text] [Related]
7. Atomic resolution structure of Erwinia chrysanthemi L-asparaginase.
Lubkowski J; Dauter M; Aghaiypour K; Wlodawer A; Dauter Z
Acta Crystallogr D Biol Crystallogr; 2003 Jan; 59(Pt 1):84-92. PubMed ID: 12499544
[TBL] [Abstract][Full Text] [Related]
8. Expression of a recombinant bacterial L-asparaginase in human cells.
Dantas RC; Caetano LF; Torres ALS; Alves MS; Silva ETMF; Teixeira LPR; Teixeira DC; de Azevedo Moreira R; Fonseca MHG; Gaudêncio Neto S; Martins LT; Furtado GP; Tavares KCS
BMC Res Notes; 2019 Dec; 12(1):794. PubMed ID: 31806048
[TBL] [Abstract][Full Text] [Related]
9. Analytical validation of a microplate reader-based method for the therapeutic drug monitoring of L-asparaginase in human serum.
Lanvers C; Vieira Pinheiro JP; Hempel G; Wuerthwein G; Boos J
Anal Biochem; 2002 Oct; 309(1):117-26. PubMed ID: 12381370
[TBL] [Abstract][Full Text] [Related]
10. Pseudomonas aeruginosa recombinant L-asparaginase: Large scale production, purification, and cytotoxicity on THP-1, MDA-MB-231, A549, Caco2 and HCT-116 cell lines.
Saeed H; Hemida A; Abdel-Fattah M; Eldoksh A; Shalaby M; Nematalla H; El-Nikhely N; Elkewedi M
Protein Expr Purif; 2021 May; 181():105820. PubMed ID: 33440252
[TBL] [Abstract][Full Text] [Related]
11. Expression and Functional Characterization of Pseudomonas aeruginosa Recombinant L.Asparaginase.
Saeed H; Soudan H; El-Sharkawy A; Farag A; Embaby A; Ataya F
Protein J; 2018 Oct; 37(5):461-471. PubMed ID: 30097831
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic drug monitoring of asparaginase in the ALL-BFM 2000 protocol between 2000 and 2007.
Schrey D; Borghorst S; Lanvers-Kaminsky C; Hempel G; Gerss J; Möricke A; Schrappe M; Boos J
Pediatr Blood Cancer; 2010 Jul; 54(7):952-8. PubMed ID: 20108339
[TBL] [Abstract][Full Text] [Related]
13. Allergic reactions and antiasparaginase antibodies in children with high-risk acute lymphoblastic leukemia: A children's oncology group report.
Ko RH; Jones TL; Radvinsky D; Robison N; Gaynon PS; Panosyan EH; Avramis IA; Avramis VI; Rubin J; Ettinger LJ; Seibel NL; Dhall G
Cancer; 2015 Dec; 121(23):4205-11. PubMed ID: 26308766
[TBL] [Abstract][Full Text] [Related]
14. A left-handed crossover involved in amidohydrolase catalysis. Crystal structure of Erwinia chrysanthemi L-asparaginase with bound L-aspartate.
Miller M; Rao JK; Wlodawer A; Gribskov MR
FEBS Lett; 1993 Aug; 328(3):275-9. PubMed ID: 8348975
[TBL] [Abstract][Full Text] [Related]
15. Rapid large-scale preparation of recombinant Erwinia chrysanthemi L-asparaginase.
Goward CR; Stevens GB; Tattersall R; Atkinson T
Bioseparation; 1992; 2(6):335-41. PubMed ID: 1368993
[TBL] [Abstract][Full Text] [Related]
16. Structures of two highly homologous bacterial L-asparaginases: a case of enantiomorphic space groups.
Jaskólski M; Kozak M; Lubkowski J; Palm G; Wlodawer A
Acta Crystallogr D Biol Crystallogr; 2001 Mar; 57(Pt 3):369-77. PubMed ID: 11223513
[TBL] [Abstract][Full Text] [Related]
17. One-step purification and kinetic properties of the recombinant L-asparaginase from Erwinia carotovora.
Krasotkina J; Borisova AA; Gervaziev YV; Sokolov NN
Biotechnol Appl Biochem; 2004 Apr; 39(Pt 2):215-21. PubMed ID: 15032742
[TBL] [Abstract][Full Text] [Related]
18. Saccharomyces cerevisiae asparaginase II, a potential antileukemic drug: Purification and characterization of the enzyme expressed in Pichia pastoris.
Facchinetti de Castro Girão L; Gonçalves da Rocha SL; Sobral RS; Dinis Ano Bom AP; Franco Sampaio AL; Godinho da Silva J; Ferrara MA; Pinto da Silva Bon E; Perales J
Protein Expr Purif; 2016 Apr; 120():118-25. PubMed ID: 26714301
[TBL] [Abstract][Full Text] [Related]
19. Erwinia chrysanthemi L-asparaginase: epitope mapping and production of antigenically modified enzymes.
Moola ZB; Scawen MD; Atkinson T; Nicholls DJ
Biochem J; 1994 Sep; 302 ( Pt 3)(Pt 3):921-7. PubMed ID: 7945221
[TBL] [Abstract][Full Text] [Related]
20. A potential type-II L-asparaginase from marine isolate Bacillus australimaris NJB19: Statistical optimization, in silico analysis and structural modeling.
Chakravarty N; Priyanka ; Singh J; Singh RP
Int J Biol Macromol; 2021 Mar; 174():527-539. PubMed ID: 33508362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
